We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

0 hedge funds and large institutions have $0 invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1380 (-138)

100% less funds holding in top 10

Funds holding in top 10: 90 (-9)

100% less capital invested

Capital invested by funds: $1.91B → $0 (-$1.91B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 138

Holders
Holders Change
-138
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
138
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DM
1
Deerfield Management
New York
-$446M -4,449,103 Closed
Fidelity Investments
2
Fidelity Investments
Massachusetts
-$180M -1,792,398 Closed
Millennium Management
3
Millennium Management
New York
-$116M -1,160,114 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
-$88.5M -882,423 Closed
BFA
5
BlackRock Fund Advisors
California
-$67.7M -675,306 Closed
Franklin Resources
6
Franklin Resources
California
-$67.6M -673,750 Closed
JHIU
7
Janus Henderson Investors US
Colorado
-$62.7M -625,683 Closed
AAM
8
Alpine Associates Management
Florida
-$58.3M -581,900 Closed
WIC
9
Water Island Capital
New York
-$51M -508,191 Closed
JP Morgan Chase
10
JP Morgan Chase
New York
-$45.2M -450,734 Closed
State Street
11
State Street
Massachusetts
-$44.5M -443,872 Closed
RG
12
Redmile Group
California
-$41.9M -417,533 Closed
WSA
13
Wall Street Associates
California
-$32.7M -326,332 Closed
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
-$32.6M -325,000 Closed
GCL
15
Glazer Capital LLC
New York
-$32.5M -324,517 Closed
Deutsche Bank
16
Deutsche Bank
Germany
-$29.4M -293,254 Closed
AA
17
AQR Arbitrage
Connecticut
-$28.9M -288,468 Closed
BIT
18
BlackRock Institutional Trust
California
-$28.4M -283,394 Closed
DKCM
19
Davidson Kempner Capital Management
New York
-$27.6M -275,000 Closed
BAMCO Inc
20
BAMCO Inc
New York
-$25.1M -250,000 Closed
WC
21
Weatherbie Capital
Massachusetts
-$18.8M -187,929 Closed
MF
22
Magnetar Financial
Illinois
-$17.6M -175,694 Closed
PCM
23
Pentwater Capital Management
Florida
-$15.1M -150,200 Closed
Stifel Financial
24
Stifel Financial
Missouri
-$14M -139,500 Closed
CCM
25
Chicago Capital Management
Illinois
-$13.7M -136,827 Closed

ASPX Hedge Fund Activity: Q2 2015 in Review

0 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q2 2015, worth a combined $0 — down 100% from $1.91B a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of ASPX and 0 opened new positions — a net loss of 138 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $446M sold.

  • 0 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q2 2015, down from 138 in Q1 2015.
  • Funds reported $0 of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 138 closed out, a net change of -138 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Deerfield Management, an estimated $446M sold.

Based on aggregated 13F filings for Q2 2015.